ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 114 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q3 2021. The put-call ratio across all filers is 0.53 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $10,000 | -23.1% | 7,403 | 0.0% | 0.00% | – |
Q4 2021 | $13,000 | -18.8% | 7,403 | 0.0% | 0.00% | -100.0% |
Q3 2021 | $16,000 | -38.5% | 7,403 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $26,000 | -64.4% | 7,403 | 0.0% | 0.00% | -66.7% |
Q1 2021 | $73,000 | -8.8% | 7,403 | 0.0% | 0.00% | -25.0% |
Q4 2020 | $80,000 | +5.3% | 7,403 | 0.0% | 0.00% | +33.3% |
Q3 2020 | $76,000 | -43.7% | 7,403 | +14.8% | 0.00% | -50.0% |
Q2 2020 | $135,000 | +150.0% | 6,451 | +17.1% | 0.01% | +100.0% |
Q1 2020 | $54,000 | +5.9% | 5,510 | +25.3% | 0.00% | +50.0% |
Q4 2019 | $51,000 | +112.5% | 4,398 | 0.0% | 0.00% | +100.0% |
Q3 2019 | $24,000 | -53.8% | 4,398 | 0.0% | 0.00% | -50.0% |
Q2 2019 | $52,000 | +126.1% | 4,398 | 0.0% | 0.00% | +100.0% |
Q1 2019 | $23,000 | +64.3% | 4,398 | 0.0% | 0.00% | 0.0% |
Q4 2018 | $14,000 | -48.1% | 4,398 | 0.0% | 0.00% | 0.0% |
Q3 2018 | $27,000 | +17.4% | 4,398 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $23,000 | +475.0% | 4,398 | +191.5% | 0.00% | – |
Q1 2017 | $4,000 | – | 1,509 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Casdin Capital, LLC | 420,000 | $1,134,000 | 0.67% |
EcoR1 Capital, LLC | 874,447 | $2,361,000 | 0.60% |
VHCP Management II, LLC | 280,000 | $756,000 | 0.31% |
683 Capital Management, LLC | 350,000 | $945,000 | 0.15% |
AWM Investment Company, Inc. | 400,000 | $1,080,000 | 0.10% |
JW Asset Management, LLC | 178,654 | $482,000 | 0.10% |
TFS CAPITAL LLC | 89,156 | $241,000 | 0.08% |
Rhenman & Partners Asset Management AB | 154,006 | $416,000 | 0.07% |
SABBY MANAGEMENT, LLC | 282,630 | $763,000 | 0.04% |
Numeric Investors LLC | 1,087,967 | $2,938,000 | 0.03% |